Indeed, when comparing predicted tumor cell killing between baseline tissues, tumor growth correlates negatively with baseline CD8+ T cell content, and is attenuated when simulated therapy is applied (Fig. 6c). The gene discussed is CD8A; the disease is neoplasm.